Agreed. Let's see how we go with that. Too many people at Tesserent focused on retaining their director fees and salaries, I suspect this doesn't always align with shareholder interests
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025